Please use this identifier to cite or link to this item:
http://20.193.157.4:9595/xmlui/handle/123456789/2376
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nemagouda S. | - |
dc.date.accessioned | 2020-05-21T06:40:53Z | - |
dc.date.available | 2020-05-21T06:40:53Z | - |
dc.date.issued | 2014-04 | - |
dc.identifier.uri | http://hdl.handle.net/123456789/2376 | - |
dc.description.abstract | Systemic corticosteroids are routinely used for the treatment of acute exacerbation of COPD (AECOPD). Preliminary studies have demonstrated that nebulised budesonide to be as efficacious as parental steroids in AECOPD. | en_US |
dc.language.iso | en | en_US |
dc.publisher | B.L.D.E.(Deemed to be University) | en_US |
dc.subject | COPD, FVC, FEV1, PEFR, SGRQ. | en_US |
dc.title | Clinical efficacy of nebulized budesonide in acute exacerbation of COPD. | en_US |
dc.type | Article | en_US |
Appears in Collections: | Faculty of Respiratory Medicine |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.